{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:00:53Z","timestamp":1753441253667,"version":"3.40.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,14]]},"abstract":"<jats:p>Lymphovascular invasion (LVI) predicts poor survival in patients with pathologically localized or locally advanced upper urinary tract urothelial carcinoma (UT-UC). However, LVI is associated with high tumor grade, tumor necrosis, advanced tumor stage, tumor location, concomitant carcinoma in situ, lymph node metastasis, and sessile tumor architecture. These factors might interfere with the analysis of the impact of LVI on oncological prognosis. To address this, this study aimed to clarify the relationship between LVI and patient prognosis in UT-UC using propensity score weighting. Data were collected from 789 patients with UT-UC treated with radical nephroureterectomy without chemotherapy. We evaluated the significance of LVI in predicting metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival (OS) using propensity score weighting. All weighted baseline characteristics included in the propensity score model were balanced between the LVI (+) and LVI (\u2212) groups. The MFS, CSS, and OS were all significantly poorer in the LVI (+) group. For patients without LVI, the 5-year MFS, CSS, and OS rates were 65.3%, 73.1%, and 67.3%, respectively, whereas the corresponding rates were 50.2%, 63.8 %, and 54.6%, respectively, for patients with LVI. (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). For patients without LVI, the 10-year MFS, CSS, and OS rates were 61.5%, 69.6%, and 59.2%, respectively, whereas those for patients with LVI were 44.5%, 57.0%, and 42.7%, respectively (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). LVI is an important pathological feature that predicts metastasis development and worse survival outcome after radical surgery in UT-UC patients.<\/jats:p>","DOI":"10.1097\/md.0000000000033485","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T14:03:24Z","timestamp":1681481004000},"page":"e33485","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic impact of lymphovascular invasion for upper urinary tract urothelial carcinoma: A propensity score-weighted analysis"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1297-7922","authenticated-orcid":false,"given":"Yin Lun","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen Ta","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung Hen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po Hui","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Tso","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih Hsiung","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao Chi","family":"Chuang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Chin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Chou","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui Ying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Li","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Chieh","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Min","family":"Tse","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao Lun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-5347(05)67019-X","article-title":"Upper tract urothelial neoplasms: incidence and survival during the last 2 decades.","volume":"164","author":"Munoz","year":"2000","journal-title":"J Urol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0090-4295(02)01529-7","article-title":"Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan.","volume":"59","author":"Yang","year":"2002","journal-title":"Urology"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/iju.14188","article-title":"Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: direct comparison from Taiwan-Japan UTUC collaboration cohort.","volume":"27","author":"Luo","year":"2020","journal-title":"Int J Urol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/MOU.0b013e3282f4a9ca","article-title":"Laparoscopic nephroureterectomy: long-term outcomes.","volume":"18","author":"Eng","year":"2008","journal-title":"Curr Opin Urol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2007.08.019","article-title":"Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.","volume":"178","author":"Saito","year":"2007","journal-title":"J Urol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2009.07.1350","article-title":"Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.","volume":"75","author":"Kim","year":"2010","journal-title":"Urology"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.31372","article-title":"Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.","volume":"124","author":"Danzig","year":"2018","journal-title":"Cancer"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1464-410X.2008.07749.x","article-title":"Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.","volume":"102","author":"Akao","year":"2008","journal-title":"BJU Int"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1464-410X.2008.07988.x","article-title":"Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma value of lymph-node density.","volume":"103","author":"Bolenz","year":"2009","journal-title":"BJU Int"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cncr.22970","article-title":"Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.","volume":"110","author":"Novara","year":"2007","journal-title":"Cancer"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2008.17.2361","article-title":"Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.","volume":"27","author":"Kikuchi","year":"2009","journal-title":"J Clin Oncol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.eururo.2009.12.029","article-title":"Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study.","volume":"57","author":"Novara","year":"2010","journal-title":"Eur Urol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1245\/s10434-014-4103-x","article-title":"Prognostic significance of lymphovascular invasion in upper urinary tract urothelial carcinoma is influenced by tumor location.","volume":"22","author":"Lee","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/UROS.UROS_58_22","article-title":"The cancer behavior and current treatment strategy for upper urinary tract cancer.","volume":"33","author":"Luo","year":"2022","journal-title":"Urol Sci"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1827.2009.02477.x","article-title":"Non-invasive papillary urothelial neoplasms: the 2004 WHO\/ISUP classification system.","volume":"60","author":"Miyamoto","year":"2010","journal-title":"Pathol Int"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours.","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours.","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/2229-516X.106353","article-title":"Histopathologic changes following neoadjuvant chemotherapy in various malignancies.","volume":"2","author":"Sethi","year":"2012","journal-title":"Int J App Basic Med Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1245\/s10434-014-3737-z","article-title":"Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.","volume":"21","author":"Ida","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00520-017-3924-0","article-title":"Clinical utility of bioelectrical impedance analysis in patients with locoregional muscle invasive or metastatic urothelial carcinoma: a subanalysis of changes in body composition during neoadjuvant systemic chemotherapy.","volume":"26","author":"Miyake","year":"2018","journal-title":"Support Care Cancer"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1245\/s10434-019-08128-7","article-title":"Neoadjuvant chemotherapy benefits survival in high-grade upper tract urothelial carcinoma: a propensity score-based analysis.","volume":"27","author":"Chen","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1464-410X.2012.11413.x","article-title":"Time to define an international standard of postoperative care for resected upper urinary tract transitional cell carcinoma (TCC) - opening of the peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (POUT) Trial.","volume":"110","author":"Birtle","year":"2012","journal-title":"BJU Int"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1016\/j.clgc.2017.10.014","article-title":"Selected high-risk patients with upper tract urothelial carcinoma treated with radical nephroureterectomy for adjuvant chemotherapy: a multi-institutional retrospective study.","volume":"16","author":"Ikeda","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-410X.2011.10893.x","article-title":"Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy the impact of lymphovascular invasion.","volume":"110","author":"Godfrey","year":"2012","journal-title":"BJU Int"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/bju.12116","article-title":"Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.","volume":"111","author":"Hurel","year":"2013","journal-title":"BJU Int"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0022-5347(17)37028-3","article-title":"The prognostic significance of vascular invasion in upper urinary tract transitional cell carcinoma.","volume":"148","author":"Hasui","year":"1992","journal-title":"J Urol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"729686","DOI":"10.3389\/fsurg.2021.729686","article-title":"Open nephroureterectomy compared to laparoscopic in upper urinary tract urothelial carcinoma: a meta-analysis.","volume":"8","author":"Liu","year":"2021","journal-title":"Front Surg"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12957-021-02236-z","article-title":"Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis.","volume":"19","author":"Piszczek","year":"2021","journal-title":"World J Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:41:46Z","timestamp":1746326506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000033485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":30,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000033485","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}